Inventor
HARTZ RICHARD A
US22 patents
⚠️ This page may combine multiple inventors who share the name “HARTZ RICHARD A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
12 patentsUS10752609B2Aug 25, 2020
GSK-3 inhibitors
BRISTOL MYERS SQUIBB CO6 citations72
US10253027B2Apr 9, 2019
Aryl lactam kinase inhibitors
BRISTOL MYERS SQUIBB CO3 citations72
US7112585B2Sep 26, 2006
Pyrimidine derivatives as corticotropin releasing factor inhibitors
BRISTOL MYERS SQUIBB CO3 citations62
US7098217B2Aug 29, 2006
3,7-dihydro-purine-2,6-dione derivatives as CRF receptor ligands
BRISTOL MYERS SQUIBB CO3 citations62
US7030145B2Apr 18, 2006
Pyridinyl derivatives for the treatment of depression
BRISTOL MYERS SQUIBB CO3 citations62
US10774086B2Sep 15, 2020
GSK-3 inhibitors
BRISTOL MYERS SQUIBB CO0 citations51
US9932320B2Apr 3, 2018
Quinoline-based kinase inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US8372847B2Feb 12, 2013
Pyrazinone modulator of corticotropin-releasing factor receptor activity
BRISTOL MYERS SQUIBB CO0 citations51
US7932256B2Apr 26, 2011
(S)-4-(1-cyclopropyl-2-methoxyethyl)-6-(6-(difluoromethoxy)-2,5-dimethylpyridin-3-ylamino)-5-oxo-4,5-dihydropyrazine-2-carbonitrile: a pyrazinone modulator of corticotropin-releasing factor receptor activity
BRISTOL MYERS SQUIBB CO0 citations51
US11970511B2Apr 30, 2024
Tetrahydropyran-based thiodisaccharide mimics as Galectin-3 inhibitors
BRISTOL MYERS SQUIBB CO0 citations50
US9249180B2Feb 2, 2016
C-3 alkyl and alkenyl modified betulinic acid derivatives
BRISTOL MYERS SQUIBB CO0 citations42
US10035777B2Jul 31, 2018
Heterocyclic kinase inhibitors
BRISTOL MYERS SQUIBB CO0 citations41
BRISTOL MYERS SQUIBB PHARMA CO
3 patentsUS7319100B2Jan 15, 2008
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
BRISTOL MYERS SQUIBB PHARMA CO3 citations62
US7205306B2Apr 17, 2007
Substituted pyrazinones, pyridines and pyrimidines as corticotropin releasing factor ligands
BRISTOL MYERS SQUIBB PHARMA CO2 citations62
US6894045B2May 17, 2005
Tetrahydropurinones and derivatives thereof as corticotropin releasing factor receptor ligands
BRISTOL MYERS SQUIBB PHARMA CO3 citations62